company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:12:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1136000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:12:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2418000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:12:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3554000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:12:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3554000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:12:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,270000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:12:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:12:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:12:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-265000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:12:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3819000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:12:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3819000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:12:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3819000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:12:27+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,1011000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:12:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4830000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:12:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:12:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-172.8
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:12:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:12:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-172.8
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:12:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27952.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:12:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-172.8
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:12:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1142000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:12:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2513000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:12:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3655000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:12:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3655000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:12:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,249000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:12:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:12:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,118000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:12:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-131000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:12:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3786000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:12:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3786000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:12:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3786000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:12:18+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,1022000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:12:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4808000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:12:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:12:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-171.13
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:12:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:12:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-171.13
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:12:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28095.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:12:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-171.13
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2240000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4197000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-3732000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10169000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6437000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,192000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3825000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-744000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10913000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10913000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,4194000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6719000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,9000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6728000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-365.64
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-365.64
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29463.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-204.09
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2841000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5251000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8092000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8092000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,157000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2559000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2712000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10804000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10804000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10804000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:53+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,204000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11008000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,10800000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.02
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,10800000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.02
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,10822325.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.02
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4372000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6806000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:25+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11178000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11178000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,185000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-177000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11355000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11355000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11355000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:25+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11355000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17700000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.64
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17700000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.64
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17684563.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:10:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.64
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:13:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:13:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3725000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:13:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7489000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:13:03+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:13:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11214000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:13:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11214000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:13:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:13:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,21000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:13:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,21000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:13:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11193000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:13:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11193000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:13:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11193000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:13:03+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:13:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11193000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:13:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17800000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:13:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.63
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:13:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17800000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:13:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.63
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:13:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17706645.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:13:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.63
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4710000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9907000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14617000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14617000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,30000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,30000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14587000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14587000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14587000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14587000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16000000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.71
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16000000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.71
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,16070054.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.71
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 16:06:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5445000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 16:06:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8692000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 16:06:53+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 16:06:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14137000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 16:06:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14137000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 16:06:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 16:06:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,53000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 16:06:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,53000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 16:06:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14084000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 16:06:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14084000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 16:06:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14084000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 16:06:53+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 16:06:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14084000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 16:06:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17800000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 16:06:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.79
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 16:06:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17800000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 16:06:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.79
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 16:06:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17815515.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2015-05-11 16:06:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.79
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:10:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,184000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:10:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,184000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:10:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,184000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:10:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4519000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:10:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11875000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:10:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16394000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:10:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16210000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:10:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,34000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:10:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,34000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:10:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16176000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:10:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16176000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:10:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16176000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:10:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16176000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:10:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18800000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:10:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.86
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:10:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18800000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:10:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.86
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:10:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18852814.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:10:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.86
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,2015-11-10 16:13:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,2015-11-10 16:13:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4857000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,2015-11-10 16:13:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12142000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,2015-11-10 16:13:03+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,2015-11-10 16:13:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16999000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,2015-11-10 16:13:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16999000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,2015-11-10 16:13:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,2015-11-10 16:13:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,55000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,2015-11-10 16:13:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,55000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,2015-11-10 16:13:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16944000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,2015-11-10 16:13:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16944000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,2015-11-10 16:13:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16944000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,2015-11-10 16:13:03+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,2015-11-10 16:13:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16944000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,2015-11-10 16:13:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20700000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,2015-11-10 16:13:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.82
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,2015-11-10 16:13:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20700000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,2015-11-10 16:13:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.82
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,2015-11-10 16:13:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20592840.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,2015-11-10 16:13:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.82
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4419000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11262000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15681000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15681000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,46000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,46000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15635000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15635000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15635000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15635000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20300000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.62
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20300000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.62
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20320628.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.62
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,2017-08-10 16:11:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,2017-08-10 16:11:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4656000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,2017-08-10 16:11:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11032000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,2017-08-10 16:11:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15688000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,2017-08-10 16:11:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15688000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,2017-08-10 16:11:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,66000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,2017-08-10 16:11:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,66000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,2017-08-10 16:11:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15622000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,2017-08-10 16:11:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15622000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,2017-08-10 16:11:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15622000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,2017-08-10 16:11:55+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,2017-08-10 16:11:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15622000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,2017-08-10 16:11:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20800000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,2017-08-10 16:11:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.75
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,2017-08-10 16:11:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20800000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,2017-08-10 16:11:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.75
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,2017-08-10 16:11:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20726108.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,2017-08-10 16:11:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.75
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:09:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,162000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:09:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,162000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:09:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,162000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:09:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4338000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:09:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10061000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:09:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14399000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:09:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14237000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:09:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,61000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:09:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,61000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:09:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14176000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:09:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14176000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:09:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14176000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:09:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14176000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:09:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20800000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:09:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.68
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:09:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20800000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:09:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.68
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:09:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20752416.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:09:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.68
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 16:10:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,133000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 16:10:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,133000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 16:10:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,133000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 16:10:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5496000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 16:10:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8876000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 16:10:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14372000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 16:10:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14239000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 16:10:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,38000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 16:10:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,38000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 16:10:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14201000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 16:10:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14201000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 16:10:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14201000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 16:10:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14201000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 16:10:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20900000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 16:10:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.68
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 16:10:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20900000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 16:10:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.68
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 16:10:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20791644.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 16:10:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.68
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:17:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:17:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4066000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:17:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9068000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:17:04+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,2234000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:17:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15368000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:17:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15368000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:17:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:17:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,143000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:17:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,143000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:17:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15225000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:17:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15225000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:17:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15225000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:17:04+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,8766000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:17:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23991000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:17:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20900000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:17:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.15
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:17:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20900000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:17:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.15
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:17:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20794193.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:17:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.15
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:43:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:43:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4137000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:43:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8527000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:43:37+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,2548000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:43:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15212000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:43:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15212000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:43:37+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:43:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,179000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:43:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,179000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:43:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15033000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:43:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15033000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:43:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15033000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:43:37+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,4111000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:43:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19144000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:43:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20800000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:43:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.92
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:43:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20800000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:43:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.92
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:43:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20841728.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:43:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.92
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,897000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,897000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,897000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3139000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9417000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4261000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16817000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15920000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,179000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,179000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15741000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15741000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15741000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,3378000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,3837000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22956000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21900000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.91
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21900000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.91
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21917415.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.91
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1545000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1545000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1545000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4335000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9893000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,3184000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17412000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15867000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,288000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,288000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15579000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15579000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15579000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15579000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51900000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51900000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51723349.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:17:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1545000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:17:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1545000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:17:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1545000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:17:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4760000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:17:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10339000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:17:04+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,22244000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:17:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37343000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:17:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-35798000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:17:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,176000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:17:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,330000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:17:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,154000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:17:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-35644000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:17:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35644000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:17:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35644000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:17:04+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:17:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-35644000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:17:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52400000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:17:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.68
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:17:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52400000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:17:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.68
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:17:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52555751.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 16:17:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.68
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:43:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1545000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:43:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1545000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:43:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1545000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:43:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5354000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:43:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11695000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:43:37+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,3694000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:43:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20743000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:43:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19198000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:43:37+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,223000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:43:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,401000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:43:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,178000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:43:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19020000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:43:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19020000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:43:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19020000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:43:37+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:43:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19020000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:43:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54300000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:43:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:43:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54300000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:43:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:43:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54799644.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,2018-11-05 16:43:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1541000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1541000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1541000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7236000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13784000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-22000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20998000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19489000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,204000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1083000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,879000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18610000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18610000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18610000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18610000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55500000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55500000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,55616092.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3107000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3107000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3107000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9676000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21603000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31279000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28172000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2018000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2018000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26154000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26154000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26154000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26154000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68800000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68800000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.38
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68259354.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:25:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5682000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:25:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5682000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:25:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5682000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:25:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8831000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:25:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22832000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:25:40+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:25:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31663000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:25:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25981000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:25:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:25:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2136000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:25:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2136000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:25:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23845000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:25:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23845000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:25:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23845000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:25:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23845000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:25:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68100000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:25:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:25:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68100000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:25:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:25:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68323850.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:25:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8035000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8035000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8035000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10619000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30086000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:27+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,40705000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32670000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1880000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1880000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30790000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30790000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30790000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30790000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68400000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.45
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68400000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.45
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68360051.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:13:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.45
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7080000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7080000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7080000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13625000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34779000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48404000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-41363000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1503000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,193000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1693000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-39670000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39670000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39670000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-39670000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68400000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.58
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68400000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.58
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68428046.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.58
